3-({[(3R,5R)-3-Butyl-3-ethyl-7-methoxy-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-yl]methyl}amino)pentanedioic acid(CAS: 1345982-69-5)

This compound may be subject to the Globally Harmonized System (GHS) for classification and labeling of chemicals. In the European Union, it would also fall under REACH regulations. For the United States, FDA and EPA regulations may apply, particularly for pharmaceutical and environmental safety concerns.

Alternative reagents include similar benzothiazepine derivatives with different side chains or functional groups. For instance, using 3-(2-aminoethyl)-1,4-benzothiazepine derivatives or related analogs could be viable alternatives.

Research trends suggest increased interest in this compound for its potential therapeutic applications, particularly in cardiovascular and neurological research. Market trends indicate growing demand from pharmaceutical industries, driven by advancements in drug discovery.

Waste should be collected in approved containers and disposed of through professional waste disposal services. Incineration, neutralization, or other appropriate methods should be used to ensure environmental safety. Compliance with local and international regulations is crucial.